Moderna, Inc. (MRNA) Presents at J.P. Morgan 42nd Annual Healthcare Conference TranscriptSeeking Alpha • 01/09/24
Moderna Covid vaccine sales plunge by two-thirds in 2023, but meet company's $6 billion forecastCNBC • 01/08/24
Moderna Provides Business and Pipeline Updates at 42nd Annual J.P. Morgan Healthcare ConferenceAccesswire • 01/08/24
Moderna stock pops after Oppenheimer says Covid shot maker could launch more products over next two yearsCNBC • 01/02/24
Midday Movers: Moderna Rises After an Upgrade, While Apple Falls Following DowngradeInvestopedia • 01/02/24
Moderna's stock soars 10% to lead S&P 500 gainers as Oppenheimer upgrades to buyMarket Watch • 01/02/24